Literature DB >> 8781397

Use of cancer incidence data in identification of cancer causation.

E Lynge1.   

Abstract

This paper discusses the use of cancer incidence data in identification of cancer causation. Selective descriptive and analytical epidemiological studies were reviewed. These examples were taken primarily from Denmark, where the possibilities for epidemiological research are good due to the existence of many exposure and disease registers. Descriptive studies are still needed for a better understanding of cancer. Analytical studies of individual risk factors today often show relative risks of only 1.5 to 2, and these are difficult to translate into preventive recommendations. Epidemiology still remains the best available tool for identification of risk factors.

Entities:  

Mesh:

Year:  1996        PMID: 8781397      PMCID: PMC1469626          DOI: 10.1289/ehp.96104s3639

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  22 in total

1.  Epidemiology faces its limits.

Authors:  G Taubes
Journal:  Science       Date:  1995-07-14       Impact factor: 47.728

2.  Limitations of biomarkers of exposure in cancer epidemiology.

Authors:  N Pearce; S de Sanjose; P Boffetta; M Kogevinas; R Saracci; D Savitz
Journal:  Epidemiology       Date:  1995-03       Impact factor: 4.822

3.  Lung cancer: is there an association with socioeconomic status in The Netherlands?

Authors:  A J van Loon; R A Goldbohm; P A van den Brandt
Journal:  J Epidemiol Community Health       Date:  1995-02       Impact factor: 3.710

4.  Incidence of cancer in persons with occupational exposure to electromagnetic fields in Denmark.

Authors:  P Guénel; P Raskmark; J B Andersen; E Lynge
Journal:  Br J Ind Med       Date:  1993-08

5.  Risk of breast cancer among young women: relationship to induced abortion.

Authors:  J R Daling; K E Malone; L F Voigt; E White; N S Weiss
Journal:  J Natl Cancer Inst       Date:  1994-11-02       Impact factor: 13.506

6.  A prospective cohort study of vasectomy and prostate cancer in US men.

Authors:  E Giovannucci; A Ascherio; E B Rimm; G A Colditz; M J Stampfer; W C Willett
Journal:  JAMA       Date:  1993-02-17       Impact factor: 56.272

7.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase.

Authors:  K Savitsky; A Bar-Shira; S Gilad; G Rotman; Y Ziv; L Vanagaite; D A Tagle; S Smith; T Uziel; S Sfez; M Ashkenazi; I Pecker; M Frydman; R Harnik; S R Patanjali; A Simmons; G A Clines; A Sartiel; R A Gatti; L Chessa; O Sanal; M F Lavin; N G Jaspers; A M Taylor; C F Arlett; T Miki; S M Weissman; M Lovett; F S Collins; Y Shiloh
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

8.  Correspondence Re: M. Schiffman and A. Schatzkin, test reliability is critically important to molecular epidemiology: an example from studies of human papillomavirus infection and cervical neoplasia. Cancer Res. (suppl.), 54: 1944s-1947s, 1994.

Authors:  F X Bosch; S de Sanjosé; N Muñoz
Journal:  Cancer Res       Date:  1994-12-01       Impact factor: 12.701

9.  Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.

Authors:  J Lukas; D Parry; L Aagaard; D J Mann; J Bartkova; M Strauss; G Peters; J Bartek
Journal:  Nature       Date:  1995-06-08       Impact factor: 49.962

10.  Regional trends in breast cancer incidence and mortality in Denmark prior to mammographic screening.

Authors:  A H Andreasen; K W Andersen; M Madsen; H Mouridsen; K P Olesen; E Lynge
Journal:  Br J Cancer       Date:  1994-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.